Nima Ghamsari - Dec 8, 2022 Form 4 Insider Report for Blend Labs, Inc. (BLND)

Signature
/s/ Crystal Sumner, Attorney-in-fact
Stock symbol
BLND
Transactions as of
Dec 8, 2022
Transactions value $
-$2,260,098
Form type
4
Date filed
12/12/2022, 05:54 PM
Previous filing
Jun 2, 2022
Next filing
Mar 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLND Class A Common Stock Other $0 +971K $0.00 971K Dec 8, 2022 Direct
transaction BLND Class A Common Stock Sale -$1.08M -971K -100% $1.11 0 Dec 8, 2022 Direct F1
transaction BLND Class A Common Stock Other $0 +176K $0.00 176K Dec 9, 2022 Direct
transaction BLND Class A Common Stock Sale -$219K -176K -100% $1.24 0 Dec 9, 2022 Direct F2
transaction BLND Class A Common Stock Other $0 +766K $0.00 766K Dec 12, 2022 Direct
transaction BLND Class A Common Stock Sale -$964K -766K -100% $1.26 0 Dec 12, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLND Class B Common Stock Other $0 -971K -8% $0.00 11.2M Dec 8, 2022 Class A Common Stock 971K Direct F4, F5, F6
transaction BLND Class B Common Stock Other $0 -176K -1.57% $0.00 11M Dec 9, 2022 Class A Common Stock 176K Direct F4, F6, F7
transaction BLND Class B Common Stock Other $0 -766K -6.97% $0.00 10.2M Dec 12, 2022 Class A Common Stock 766K Direct F4, F6, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale price represents the weighted average sale price of the shares sold ranging from $1.09 to $1.155 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 This sale price represents the weighted average sale price of the shares sold ranging from $1.23 to $1.285 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 This sale price represents the weighted average sale price of the shares sold ranging from $1.25 to $1.3175 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4 Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date.
F5 All the shares of Class B Common Stock were previously pledged as collateral to secure certain personal indebtedness of the Reporting Person under a loan. On December 8, 2022, the Reporting Person sold the shares and used the proceeds to reduce the outstanding amount under the loan. The Reporting Person will make further sales of shares from time to time and use the proceeds to further reduce the outstanding amount under the loan as required under the loan documentation.
F6 The shares of Class B Common Stock held of record by the Reporting Person are pledged as collateral to secure certain personal indebtedness of the Reporting Person.
F7 All the shares of Class B Common Stock were previously pledged as collateral to secure certain personal indebtedness of the Reporting Person under a loan. On December 9, 2022, the Reporting Person sold the shares and used the proceeds to reduce the outstanding amount under the loan. The Reporting Person will make further sales of shares from time to time and use the proceeds to further reduce the outstanding amount under the loan as required under the loan documentation.
F8 All the shares of Class B Common Stock were previously pledged as collateral to secure certain personal indebtedness of the Reporting Person under a loan. On December 12, 2022, the Reporting Person sold the shares and used the proceeds to reduce the outstanding amount under the loan. The Reporting Person will make further sales of shares from time to time and use the proceeds to further reduce the outstanding amount under the loan as required under the loan documentation.